Related Experiment Video

Updated: Jun 27, 2026

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

Regulation of tumor-stromal fibroblast interactions: implications in anticancer therapy

Hippokratis Kiaris1, George Trimis, Athanasios G Papavassiliou

  • 1Department of Biological Chemistry, University of Athens Medical School, Athens, Greece.

Current Medicinal Chemistry
|December 17, 2008
PubMed

Insights

Targeting tumor stroma, particularly fibroblasts, offers a promising therapeutic strategy in cancer. New methods are needed to identify specific regulators for these crucial tumor-stroma interactions.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment Research

Background:

  • The tumor stroma is increasingly recognized as a key regulator of cancer development.
  • Stromal cells, especially cancer-associated fibroblasts, play a significant role in tumorigenesis.
  • Targeting tumor-stroma interactions presents a potential therapeutic strategy, but specific regulators are poorly understood.

Purpose of the Study:

  • To review the literature on the role of stromal factors, particularly fibroblasts, in tumorigenesis.
  • To examine experimental evidence supporting therapeutic interference with tumor-stroma interactions.
  • To propose a novel experimental system for screening regulators of these interactions.

Main Methods:

  • Literature review of studies on tumor biology and stromal factors.
  • Analysis of experimental evidence on targeting tumor-stroma interactions.
  • Theoretical considerations and proposal of a biological screening system.

Main Results:

  • Stromal components, especially fibroblasts, are central to cancer progression.
  • Interfering with tumor-stroma crosstalk shows therapeutic potential.
  • A novel experimental system is proposed to facilitate the screening of regulatory factors.

Conclusions:

  • The tumor stroma is a critical regulator of carcinogenesis and a potential therapeutic target.
  • Further research into tumor-stroma interactions is essential for developing novel cancer therapies.
  • The proposed experimental system could accelerate the discovery of new therapeutic targets within the tumor microenvironment.

More Related Videos

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...